Revenue: The sum of all revenue fields included for a company's operating activities.
Keros Therapeutics, Inc. (KROS) had Revenue of $3.55M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$3.55M |
$-187.35M |
|
-- |
|
$3.55M |
|
$214.38M |
|
$-210.83M |
|
$23.78M |
|
$-187.05M |
|
$-187.05M |
|
$-187.35M |
|
$-187.35M |
|
$-187.35M |
|
$-187.35M |
|
$-210.83M |
|
$-209.60M |
|
37.44M |
|
37.44M |
|
$-5.00 |
|
$-5.00 |
|
| Balance Sheet Financials | |
$588.89M |
|
$4.24M |
|
$26.99M |
|
$615.89M |
|
$27.45M |
|
-- |
|
$16.88M |
|
$44.33M |
|
$571.55M |
|
$571.55M |
|
$571.55M |
|
40.55M |
|
| Cash Flow Statement Financials | |
$-160.87M |
|
$-1.93M |
|
$391.82M |
|
$332.36M |
|
$561.38M |
|
$229.02M |
|
$34.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.45 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5938.96% |
|
-5938.96% |
|
-5904.34% |
|
-5269.10% |
|
-5277.55% |
|
$-162.80M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.29 |
|
281.92 |
|
-32.78% |
|
-32.78% |
|
-30.42% |
|
-32.78% |
|
$14.09 |
|
$-4.35 |
|
$-4.30 |
|